MedPath

Eon Labs, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

FDA:11

Drug Approvals

Metaxalone

Approval Date
May 27, 2022
FDA

Bupropion Hydrochloride

Approval Date
May 6, 2022
FDA

Rifampin

Approval Date
Mar 22, 2022
FDA

Oxaprozin

Approval Date
May 3, 2021
FDA

Etodolac

Approval Date
Mar 12, 2021
FDA

Eplerenone

Approval Date
Sep 10, 2020
FDA

cholestyramine light

Approval Date
Sep 1, 2020
FDA

Cholestyramine

Approval Date
Aug 11, 2020
FDA

Sulfadiazine

Approval Date
Jun 30, 2020
FDA

Quinidine Sulfate

Approval Date
Sep 13, 2019
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy